Who we are

PharmaLex India is the Indian arm of the PharmaLex Group. PharmaLex India offers great value to global customers through its flexible offshore business delivery models. Our offerings span around;

  • End-to-end regulatory services, customized to meet client requirements with the capability of delivering on a global and local level.
  • End-to-end PV support services including on ground support (Local QPPV/LSR).
  • Development Consulting and Scientific Affairs to assist with optimal strategy on your product development.
  • Our customers have a Pharmaceuticals/Biotechnology/Consumer Care/Cosmetics and Medical Devices industry background.
  • Our teams are qualified medical professionals or PhD’s with over 20 years of life science industry experience.
  • Our subject matter experts are able to offer cost-effective solutions to customers worldwide and work in close cooperation with global teams and customer project stake holders.

Local Contact

  • Rashim Sharma
    Assistant Director, Business Development and Marketing PharmaLex India 3rd Floor, Plot No. 1 and 2,
    Tower A, Maple Corporate Park,
    Sector – 125,
    Noida,
    Uttar Pradesh – 201301
    +91 120 5178478/79/80
Download Terms and Conditions

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • We really appreciate your responsiveness and availability during our previous exchanges and it is what we are waiting for from our partner.

    Small Medium Sized Company, UK
    Head of Regulatory Affairs

  • Worked with us and our contractors to help us achieve our tight targets, operate with our systems and procedures and are considered invaluable part of our team

    US based large development group
    VP Regulatory / Quality

  • I just wanted to relay our sincere thanks to you and the team for two really excellent days training. It was well organized and structured to cover regulatory expectations, GMP principle and routine work challenges of industry. The presenters and moderator were highly skilled in this area to accommodate any queries raised during the training session and were well able to keep the team engaged even in remote/virtual training session. The design of training slides was impressive and the use of technology to make virtual training was remarkable.

    Lorraine Henry
    Compliance Lead, Qualified Person, Amneal Ireland Limited

  • There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

    Large Pharma, Global
    VP Regulatory Strategy

Related News